You are viewing just a glimpse of the 100+ pieces of sophisticated insight and analysis produced by our full-time team of senior financial journalists every day. For full access, check to see if your firm has a license to The Deal Pipeline or login using your existing credentials.
Here's a preview of all of the dealmaking events you need to know about for the week of May 19th.
The HSR Act expires for British drug company GlaxoSmithKline's $720 million purchase of Sirtis Pharmaceuticals; Draxis Health shareholders will vote on the proposed merger with drug maker Jubilant; and retailers Target, Home Depot, Limited Brands, Gap, and Talbots will report and discuss earnings.
Suzanne Stevens, senior editor of Corporate Dealmaker, joins us this week with a closer look at Talbots' earnings.
Share: blog comments powered by Disqus
Leezie Kim is rejoining the Phoenix office of Quarles & Brady LLP as a partner. She will continue her corporate transactions practice. For other updates launch today's Movers & shakers slideshow.
Dechert's Henry Nassau at the 18th annual Wharton Private Equity and Venture Capital Conference tells The Deal Pipeline how to shine in the middle market. More video
Search
